126 related articles for article (PubMed ID: 35274792)
1. Comparison of Multiparametric and Fast MRI Protocols in Detecting Clinically Significant Prostate Cancer and a Detailed Cost Analysis.
Alver KH; Yagci AB; Utebey AR; Turk NS; Ufuk F
J Magn Reson Imaging; 2022 Nov; 56(5):1437-1447. PubMed ID: 35274792
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
3. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
4. Comparison between an abbreviated and full MRI protocol for detecting additional disease when doing breast cancer staging.
Girometti R; Nitti A; Lorenzon M; Greco F; Londero V; Zuiani C
J Magn Reson Imaging; 2019 Jun; 49(7):e222-e230. PubMed ID: 30350391
[TBL] [Abstract][Full Text] [Related]
5. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
[No Abstract] [Full Text] [Related]
6. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
7. Improving reader accuracy and specificity with the addition of hybrid multidimensional-MRI to multiparametric-MRI in diagnosing clinically significant prostate cancers.
Lee G; Chatterjee A; Harmath C; Karademir I; Engelmann R; Yousuf A; Islam S; Karczmar G; Oto A; Giurcanu M; Antic T; Eggener S
Abdom Radiol (NY); 2023 Oct; 48(10):3216-3228. PubMed ID: 37358605
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
9. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
Choi MH; Kim CK; Lee YJ; Jung SE
AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
[TBL] [Abstract][Full Text] [Related]
10. Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
Lee GH; Chatterjee A; Karademir I; Engelmann R; Yousuf A; Giurcanu M; Harmath CB; Karczmar GS; Oto A
Radiology; 2022 Nov; 305(2):399-407. PubMed ID: 35880981
[TBL] [Abstract][Full Text] [Related]
11. Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate.
Johnson PM; Tong A; Donthireddy A; Melamud K; Petrocelli R; Smereka P; Qian K; Keerthivasan MB; Chandarana H; Knoll F
J Magn Reson Imaging; 2022 Jul; 56(1):184-195. PubMed ID: 34877735
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a Deep Learning-Accelerated vs. Conventional T2-Weighted Sequence in Biparametric MRI of the Prostate.
Tong A; Bagga B; Petrocelli R; Smereka P; Vij A; Qian K; Grimm R; Kamen A; Keerthivasan MB; Nickel MD; von Busch H; Chandarana H
J Magn Reson Imaging; 2023 Oct; 58(4):1055-1064. PubMed ID: 36651358
[TBL] [Abstract][Full Text] [Related]
13. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
Zanelli E; Giannarini G; Cereser L; Zuiani C; Como G; Pizzolitto S; Crestani A; Valotto C; Ficarra V; Girometti R
J Magn Reson Imaging; 2019 Nov; 50(5):1604-1613. PubMed ID: 30957321
[TBL] [Abstract][Full Text] [Related]
15. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
[TBL] [Abstract][Full Text] [Related]
17. Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer.
Cereser L; Giannarini G; Bonato F; Pizzolitto S; Como G; Valotto C; Ficarra V; Dal Moro F; Zuiani C; Girometti R
Minerva Urol Nephrol; 2022 Feb; 74(1):29-37. PubMed ID: 33016030
[TBL] [Abstract][Full Text] [Related]
18. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
19. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]